PASSAGE BIO, INC. (PASG) Net income 2019–2025
PASSAGE BIO, INC. (PASG) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$45.5MFY2025 · since FY2019: -$45.6M → -$45.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$45.5M | +29.7% |
| FY2024 | -$64.8M | +36.5% |
| FY2023 | -$102.1M | +25.0% |
| FY2022 | -$136.1M | +26.6% |
| FY2021 | -$185.4M | -65.2% |
| FY2020 | -$112.2M | -145.9% |
| FY2019 | -$45.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PASG financial trends
PASG RevenuePASG Net marginPASG Gross profitPASG Gross marginPASG Operating incomePASG Operating marginPASG Operating cash flowPASG Free cash flowPASG Capital expendituresPASG Return on equityPASG Stock buybacksPASG Dividends paidPASG Total assetsPASG Total liabilitiesPASG Shareholders’ equityPASG overview →